A Blood Test for the Detection of Breast Cancer: Syantra Receives CE Mark Approval for their Breast Cancer Test built on the Syantra DX Liquid Biopsy Platform
(Adnkronos) – CALGARY, AB, April 18, 2023 /PRNewswire/ — Syantra announced today that it has obtained CE marking for the Syantra DXTM Breast Cancer test. Syantra DXTM Breast Cancer is a minimally invasive blood
